Patents by Inventor Chitturi Trinadha Rao

Chitturi Trinadha Rao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amidoheteroaryl aroyl hydrazide ethynes
    Patent number: 10150733
    Abstract: The present invention relates to novel amidoheteroaryl aroyl hydrazide ethynes as tyrosine kinase inhibitors, process of preparation thereof, and use of the compounds for preparation of pharmaceutical compositions in the therapeutic treatment of disorders related to tyrosine kinases in humans.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: December 11, 2018
    Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
    Inventors: Hemant Ashvinbhai Chokshi, Sabbirhusen Yusufbhai Chimanwala, Varun Anilkumar Mehta, Prabal Sengupta, Chitturi Trinadha Rao
  • NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES
    Publication number: 20180127372
    Abstract: The present invention relates to novel amidoheteroaryl aroyl hydrazide ethynes as tyrosine kinase inhibitors, process of preparation thereof, and use of the compounds for preparation of pharmaceutical compositions in the therapeutic treatment of disorders related to tyrosine kinases in humans.
    Type: Application
    Filed: May 18, 2016
    Publication date: May 10, 2018
    Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
    Inventors: Hemant Ashvinbhai CHOKSHI, Sabbirhusen Yusufbhai CHIMANWALA, Varun Anilkumar MEHTA, Prabal SENGUPTA, Chitturi Trinadha RAO
  • Methods for treatment of inflammatory conditions using -[4-(3-fleuro-3-methylbutyryloxy)but-2-ynyl]6?, 9?-difluoro-17?-(furan-2-yl) carbonyloxy-11?-hydroxy-16?-methyl-3-oxoandrosta-1,4-diene-17?-carbothioate
    Patent number: 9458187
    Abstract: The present invention relates to methods of treatment of inflammatory conditions using S-[4-(3-fluoro-3-methylbutyryloxy)-but-2-ynyl]6?,9?-difluoro-17?-(furan-2-yl)carbonyloxy-11?-hydroxy-16?-methyl-3-oxoandrosta-1,4-diene-17?-carbothioate (compound of formula I), a novel anti-inflammatory compound of the androstane series and its processes of preparation.
    Type: Grant
    Filed: May 28, 2014
    Date of Patent: October 4, 2016
    Assignee: Sun Pharma Advanced Research Company Limited
    Inventors: Jiten Ranchhodbhai Patel, Gopalkumar Chimanlal Patel, Gaurav Sanjivkumar Sheth, Sanjay Nandlal Mandhane, Chitturi Trinadha Rao, Rajamannar Thennati
  • METHODS FOR TREATMENT OF INFLAMMATORY CONDITIONS USING S-[4-(3- FLUORO-3-METHYLBUTYRYLOXY) BUT-2-YNYL] 6ALPHA, 9ALPHA-DIFLUORO-17ALPHA-(FURAN-2-YL) CARBONYLOXY-11BETA -HYDROXY-16ALPHA-METHYL-3-OXOANDROSTA-1,4-DIENE-17BETA - CARBOTHIOATE
    Publication number: 20160102117
    Abstract: The present invention relates to methods of treatment of inflammatory conditions using S-[4-(3-fluoro-3-methylbutyryloxy)-but-2-ynyl]6?,9?-difluoro-17?-(furan-2-yl)carbonyloxy-11?-hydroxy-16?-methyl-3-oxoandrosta-1,4-diene-17?-carbothioate (compound of formula I), a novel anti-inflammatory compound of the androstane series and its processes of preparation.
    Type: Application
    Filed: May 28, 2014
    Publication date: April 14, 2016
    Inventors: Jiten Ranchhodbhai Patel, Gopalkumar Chimanlal Patel, Gaurav Sanjivkumar Sheth, Sanjay Nandlal Mandhane, Chitturi Trinadha Rao, Rajamannar Thennati